Pharmacology · Autonomic Nervous System (Cholinergic, Anticholinergic, Sympathomimetics, Sympatholytics)

Phenoxybenzamine is used in preoperative management of phaeochromocytoma. Compared to phentolamine, which statement correctly characterises its mechanism of action?

  • A It is an irreversible non-competitive alkylating antagonist of alpha receptors
  • B It is a reversible competitive antagonist of both alpha-1 and alpha-2 receptors
  • C It blocks only alpha-1 receptors and has a short half-life
  • D It acts primarily by reducing catecholamine synthesis in the adrenal medulla
Correct answer: A. It is an irreversible non-competitive alkylating antagonist of alpha receptors

Explanation

Phenoxybenzamine forms a stable covalent bond with alpha adrenoceptors, rendering blockade irreversible (non-competitive). This is particularly useful in phaeochromocytoma as episodic catecholamine surges cannot overcome the blockade. New receptor synthesis over several days is required to restore function. Phentolamine, by contrast, is a reversible competitive antagonist. Phenoxybenzamine has no effect on catecholamine synthesis.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Autonomic Nervous System (Cholinergic, Anticholinergic, Sympathomimetics, Sympatholytics) MCQs

See all Autonomic Nervous System (Cholinergic, Anticholinergic, Sympathomimetics, Sympatholytics) MCQs →